Recent Insider Selling To Watch: Arena Pharmaceuticals (NASDAQ:ARNA), Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), JetBlue Airways Corporation (NASDAQ:JBLU), CVS Health (NYSE:CVS)


Arena Pharmaceuticals Inc (NASDAQ:ARNA) SVP William R. Shanahan, Jr. sold 50,000 shares of the company’s stock on the open market in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $5.49, for a total transaction of $274,500.00. Following the sale, the senior vice president now directly owns 50,000 shares in the company, valued at approximately $274,500. On Thursday shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $5.76. Company’s sales growth for last 5 years was 52.70%.

Facebook Inc (NASDAQ:FB),The VP, Gen. Counsel & Secretary of Facebook Inc, Stretch Colin sold 1,000 shares at $77.26 on January 6, 2015. The Insider selling transaction had a total value worth of $77,260. Facebook Inc (NASDAQ:FB) in last trading activity increased 2.66% to close at $78.18. Company weekly performance is 0.20% while its quarterly performance stands at 0.84%. Facebook Inc (NASDAQ:FB) is -4.86% away from its 52 week high.

Twitter Inc (NYSE:TWTR), Director Evan Clark Williams sold 372,000 shares of Twitter stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $36.95, for a total transaction of $13,745,400.00. On last trading day Twitter Inc (NYSE:TWTR) increased 4.86% to close at $39.09. Its volatility for the week is 5.63% while volatility for the month is 4.06%. Twitter Inc (NYSE:TWTR) monthly performance is 7.72%.

JetBlue Airways Corporation (NASDAQ:JBLU) President Robin Hayes sold 5,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $14.94, for a total transaction of $74,700.00. Following the sale, the president now directly owns 246,097 shares in the company, valued at approximately $3,676,689. JetBlue Airways Corporation (NASDAQ:JBLU) has 0.30% insider ownership. In last trading activity company’s stock closed at $14.88.

CVS Health Corp (NYSE:CVS) EVP Jonathan C. Roberts sold 86,487 shares of the company’s stock on the open market in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $95.31, for a total value of $8,243,075.97. Following the completion of the transaction, the executive vice president now directly owns 71,320 shares in the company, valued at approximately $6,797,509. On last trading day CVS Health Corporation (NYSE:CVS) increased 2.13% to close at $97.97. Its volatility for the week is 1.62% while volatility for the month is 1.65%. CVS’s sales growth for past 5 years was 7.80% and its EPS growth for past 5 years was 10.60%. CVS Health Corporation (NYSE:CVS) monthly performance is 7.94%.


Leave a Reply

Your email address will not be published. Required fields are marked *